Prevention of Future Deaths reports · 2024

Michael Pegg

Regulation 28 report to prevent future deaths, reference 2024-0306, written 26 Jan 2024. A coroner writes one of these when an inquest reveals a risk that could cause further deaths unless something changes.

Date of report26 Jan 2024
Reference2024-0306
DeceasedMichael Pegg
CoronerDavid Reid
Coroner areaWorcestershire
CategoryHospital Death (Clinical Procedures and medical management) related deaths
Organisation namedWorcestershire Acute Hospitals NHS Trust
Sourcejudiciary.uk record · original PDF
Responses published2

The report

Text extracted from the PDF text layer. Reproduced verbatim, including the scan's own layout.

REGULATION 28 REPORT TO PREVENT FUTURE DEATHS 

THIS REPORT IS BEING SENT TO: 

1) 

2) 

 Chief Executive, Worcestershire Acute Hospitals NHS Trust, 

Charles Hastings Way, Worcester WR5 1DD; 

, National Medical Director, NHS England; 

1  CORONER 

I am David Donald William REID, HM Senior Coroner for Worcestershire. 

2  CORONER’S LEGAL POWERS 

I make this report under paragraph 7, Schedule 5, of the Coroners and Justice Act 
2009 and regulations 28 and 29 of the Coroners (Investigations) Regulations 2013. 

http://www.legislation.gov.uk/ukpga/2009/25/schedule/5/paragraph/7 
http://www.legislation.gov.uk/uksi/2013/1629/part/7/made 

3 

INVESTIGATION and INQUEST 

On 28 July 2023 I commenced an investigation and opened an inquest into the death 
of Michael Leslie PEGG. The investigation concluded at the end of the inquest on 23 
January 2024 

The conclusion of the inquest was that Mr. Pegg “died from natural causes.” 

4  CIRCUMSTANCES OF THE DEATH 

In answer to the questions “when, where and how did Mr. Pegg come by his death?”, I 
recorded as follows: 

“On 13.1.23 Michael Pegg, who lived with congenital adrenal insufficiency and 
epilepsy, was admitted to Worcestershire Royal Hospital after suffering two significant 
seizures at home earlier that morning. Early the following morning he suffered a 
significant deterioration in his condition and developed pneumonia. Despite treatment, 
he continued to decline and died in hospital on 15.1.23.” 

5  CORONER’S CONCERNS 

During the course of the inquest the evidence revealed matters giving rise to concern. 
In my opinion there is a risk that future deaths will occur unless action is taken. In the 
circumstances it is my statutory duty to report to you. 

The MATTERS OF CONCERN are as follows.  –  

1)  Over the two days that Mr. Pegg was at Worcestershire Royal Hospital, those 

, who conducted the Trust’s serious 

treating him failed to apply the NICE guidelines which relate to the treatment 
of those with adrenal insufficiency conditions who are being treated for 
intercurrent illness. 
incident investigation into these events, told the inquest: 
“There was a policy in place for administering steroids, as per the 2020 NICE 
guidelines – this advises: 
(a) double dosing of oral steroids in cases of intercurrent illness until 48 hours 
after recovery ( also known as Sick Day rule 1 ); 
(b) if [ the patient has ] significant trauma, prolonged vomiting or diarrhoea, 
then 100mg IV hydrocortisone [ should be administered ]; 

1 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 (c) if suspected adrenal crisis, 100mg IV hydrocortisone immediately.” 
In fact, the steroid treatment provided to Mr. Pegg during this admission fell 
far short of those Guidelines, in that: 
(a)  He only received one double dose of his oral hydrocortisone medication, 

which he was usually required to take twice a day; 

(b)  He received no doses at all ( double or standard ) of his oral prednisolone 

medication, which he was usually required to take once a day; 

(c)  Although he did eventually receive a 100mg dose of IV hydrocortisone on 
14.1.23, this should have been given much earlier that day when his 
condition seriously deteriorated. 

2)  Although in this case, I was unable to conclude that the above omissions in 
steroid treatment probably caused or contributed to Mr. Pegg’s death, it was 
nonetheless concerning to hear that none of those treating him had sufficient 
awareness of the NICE Guidelines as to be able to apply them properly in his 
case. Unless action is taken to ensure clinicians employed by the Trust are 
aware of, and able to apply these Guidelines, there remains a risk that 
another patient with adrenal insufficiency may die in similar circumstances; 

3)  For a substantial part of his time at Worcestershire Royal Hospital, Mr. Pegg 

was being treated in a bed in a corridor in the Emergency Department, and 
then in the Majors Overflow area, both busy, crowded and noisy areas ill-
suited to the proper treatment of patients. In his evidence to the inquest about 
trying to ensure that the Trust’s staff are aware of these Guidelines, Dr. 
Raven told the inquest: 
“As long as we still have crowded settings, it is difficult to provide assurances 
that these guidelines will be followed, for example because we have a high 
turnover of locum clinicians and agency nursing staff.” 
It is particularly concerning to hear that patients’ wellbeing may be put at risk 
because a hospital Trust may not be able properly to ensure that the staff it 
employs are aware of, and able to apply NICE Guidelines. 
It is perhaps unfair to put responsibility for rectifying this situation solely at the 
door of the Worcestershire Acute Hospitals NHS Trust, which is why this 
report is also being sent to NHS England and Health Education England. 

6  ACTION SHOULD BE TAKEN 

In my opinion action should be taken to prevent future deaths and I believe you, as 
the Chief Executive of Worcestershire Acute Hospitals NHS Trust, and the National 
Medical Director of NHS England, have the power to take such action.    

7 

YOUR RESPONSE 

You are under a duty to respond to this report within 56 days of the date of this report, 
namely by 22 March 2024. I, the coroner, may extend the period. 

Your response must contain details of action taken or proposed to be taken, setting 
out the timetable for action. Otherwise you must explain why no action is proposed. 

8  COPIES and PUBLICATION 

I have sent a copy of my report to the Chief Coroner and to the following: 

(a) 

, Mr. Pegg’s widow. 

I am also under a duty to send the Chief Coroner a copy of your response.  

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 The Chief Coroner may publish either or both in a complete or redacted or summary 
form. He may send a copy of this report to any person who he believes may find it 
useful or of interest. You may make representations to me, the coroner, at the time of 
your response, about the release or the publication of your response by the Chief 
Coroner.  

9 

26 January 2024 

David REID 
HM Senior Coroner for Worcestershire 

3

Responses

2 responses published against this report on judiciary.uk. A response is a body's written reply to the coroner's concerns; publication is at the discretion of the Chief Coroner's office, so an absent response does not mean nobody replied.

Response from NHS England (PDF)
David Donald William Reid 
HM Senior Coroner 
Worcestershire Coroner’s Court 
The Civic, Martins Way 
Stourport-on-Severn 
Worcestershire  
DY13 8UN 

Dear Coroner,  

National Medical Director  
NHS England  
Wellington House 
133-155 Waterloo Road  
London 
SE1 8UG 

25 March 2024  

Re: Regulation 28 Report to Prevent Future Deaths – Michael Leslie Pegg who 
died on 15 January 2023 

Thank  you  for  your  Report  to  Prevent  Future  Deaths  (hereafter  “Report”)  dated  26 
January 2024 concerning the death of Michael Leslie Pegg on 15 January 2023. In 
advance of responding to the specific concerns raised in your Report, I would like to 
express my deep condolences to Michael’s family and loved ones. NHS England are 
keen to assure the family and the  coroner that the concerns raised about  Michael’s 
care have been listened to and reflected upon. 

In your report you raised concerns that those treating Michael failed to follow National 
Institute for Health and Care Excellence (NICE) guidelines relating to the treatment of 
those  with  adrenal  insufficiency  conditions  who  are  being  treated  for  intercurrent 
illness. NICE are responsible for producing these clinical guidelines and NHS Trusts 
and bodies are expected to pay due regard to NICE and Royal College guidelines. As 
you note in your Report, there is existing guidance on this issue from NICE. They are 
also due to publish updated guidance on Adrenal insufficiency: acute and long-term 
management later this year.  

NHS  England  has  also  worked  closely  with  the  Society  for  Endocrinology  and  the 
Royal College of Physicians on the issue of under-recognition and treatment of adrenal 
insufficiency  or  crisis.  This  culminated  in  the  publication  of  ‘Guidance  for  the 
prevention and emergency management of adult patients with adrenal insufficiency’ in 
July  2020,  which  outlines  the  causes  of  adrenal  insufficiency,  groups  at  risk  of  an 
adrenal crisis, emergency management and management for surgical procedures. As 
a result of work in this area, a new NHS Steroid Emergency Card was developed, to 
be  carried  by  patients  at  risk  of  adrenal  crisis  and  ensure  the  prompt  delivery  of 
steroids to those patients presenting within an emergency or acute medicine setting.    

                                                                                                                       
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
   
 invasive  procedures, 

including  day  patients,  should 

The work above also resulted in the publication of the  National Patient Safety Alert 
(NatPSA),  which  includes  the  specific  action  that  ‘Providers  that  treat  patients  with 
acute physical illness or trauma, or who may require emergency or elective surgical or 
their 
other 
admission/assessment/examination/clerking  documentation  to  ensure  it  includes 
prompts to check for risk of adrenal crisis and to establish if the patient has a Steroid 
Emergency Card.’ Trusts were expected to implement actions around this specific alert 
by 13 May 2021 and Worcestershire Acute Hospitals NHS Trust is recorded as being 
compliant with this. We also note that it appears that the Trust has an internal guideline 
on  the  management  of  adrenal  insufficiency,  published  in  March  2022.  The  Royal 
College  of  Emergency  Medicine  (RCEM)  has  also  issued  professional  guidance  on 
Addisonian Crisis.   

review 

Your  Report  also  raised  the  concern  that  Michael  received  treatment  in  the  Resus 
Corridor and in the Major’s Overflow area and that the noisy and crowded conditions 
put proper treatment of patients at risk. NHS England recognises that services across 
the  NHS  are  currently  facing  significant  pressures.  NHS  England  is  committed  to 
improving patient experience within hospitals and in January 2023 we published a two-
year Delivery plan for recovering urgent and emergency care services. The plan aims 
to relieve pressures on emergency departments by:   

•  Growing the workforce available for 111 online and urgent call services to offer 

support, advice, diagnosis and referral.   

•  Expanding services within the community to prevent avoidable A&E admission. 
This will include more joined-up urgent care within the community and use of 
virtual wards.  

•  Helping people access the right care first time, ensuring that 111 is the first port 

of call and reducing the need for people needing to go to A&E.   

•  Growing capacity and number of beds within hospitals to relieve pressures on 

A&E Departments.   

NHS England would refer you to the Trust on what actions are being taken locally to 
address your concerns. We have been sighted on their Serious Investigation Report 
and  Action  Plan  and  note  that  they  have  taken  learnings  around  Emergency 
Department  crowding  and  improving  end-of-life  care  for  patients  and  are  reviewing 
staffing levels in the Overflow Area and Acuity.  

I would also like to provide further assurances on national NHS England work taking 
place around the Reports to Prevent Future Deaths. All reports received are discussed 
by  the  Regulation  28  Working  Group,  comprising  Regional  Medical  Directors,  and 
other clinical and quality colleagues from across the regions. This ensures that key 
learnings and insights around preventable deaths are shared across the NHS at both 
a national and regional level and helps us pay close attention to any emerging trends 
that may require further review and action.   

Thank you for bringing these important patient safety issues to my attention and please 
do not hesitate to contact me should you need any further information. 

 
  
 
 
 
 
 
 
 Yours sincerely, 

National Medical Director
Response from Worcestershire Acute Hospitals NHS Trust (PDF)
Office of the Managing Director  
MD: Mr Stephen Collman 

22 March 2024 

Mr D D W Reid  
H M Senior Coroner 
Worcestershire Coroner’s Court  
Martins Way  
Stourport-on-Severn 
Worcestershire 
DY13 8UN 

Dear Mr Reid  

Re: Mr Michael Pegg deceased 
Regulation 28 Report to Prevent Future Deaths 

Thank you for forwarding on your Regulation 28 report. I have read your report with great care and note 
the concerns that you have raised as a result of the coronial inquiry into the death of Mr Michael Pegg.  

In your Regulation 28 report you identified the following matters of concern relating to the Worcestershire 
Acute Hospitals NHS Trust (WAHT) and I will respond to these concerns below, as a sequence, where 
appropriate. 

Concerns 

1)  The steroid treatment provided to Mr Pegg during this admission fell far short the guidelines. 

2)  None of those treating him had sufficient awareness of the NICE Guidelines as to be able to 

apply them properly in his case. Unless action is taken to ensure clinicians employed by the Trust 
are aware of, and are able to apply these Guidelines, there remains a risk that another patient 
with adrenal insufficiency may die in similar circumstances. 

3)  Patient’s wellbeing may be put at risk because a Hospital Trust may not be able properly to 

ensure that the staff it employs are aware of, and able to apply NICE Guidelines 

The Trust has now implemented both further learning and additional checks, to ensure that steroid 
treatment provided to future patients will not fall short of the NICE Guidelines in the future. I have noted 
the actions taken below and I hope that they will ensure clinicians employed by the Trust are aware of, 
and are able to apply the relevant Guidelines in the future. 

•  Steroid replacement therapy has been discussed in both the Trust Patient Safety Incident 

Response Group and the Deteriorating Patient, Resuscitation, End of Life and Mortality Group on  

Worcestershire Acute Hospitals NHS Trust | Executive Suite, Sky Level 3 | Worcestershire Royal Hospital 
Charles Hastings Way | Worcester | WR5 1DD 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Office of the Managing Director  

several occasions since Mr Pegg’s sad death. Discussions included the importance of the adult 
patient document in the Emergency Department which was updated in June 2023.  This now  

includes a time critical medications (highlighted steroid replacement) (please see appendix 1 
attached). This is automatically included for all adults presenting to the Emergency Department. 

•  A “detect and reflect” document and “time critical medication safety flash” have been circulated to 
all Emergency and Medical staff to raise awareness of the need for steroid replacement therapy 
(appendix 2, 3). These are displayed in the Emergency Department handover area.  

•  Steroid replacement (and other time critical meds) has been highlighted in effective handover in 
ED in 2023 and will be repeated (appendix 4) to raise and maintain awareness for all medical 
staff working in the ED. 

•  The Trust is due to move to an electronic patient record in the Emergency Department in Autumn 

2024 – time critical medications including steroids are due to be incorporated into this.  

•  The Emergency Departments on both sites are participating in a Royal College of Emergency 

Medicine audit looking at the prescribing and administration of time critical medicines, including 
steroids. This audit will provide a “benchmark” for the Trust and also highlight areas where further 
improvement is required. The audit is still in data collection phase but results will be available 
later in the year. 

•  The Acting Chief Medical Officer will be attending the Induction for new doctors in August in order 

to highlight this area of focus for the Trust for all junior doctors rotating into our hospitals. 

•  The Medical Examiners, at the request of the Trust, are working with Adrenal 

Insufficiency/Steroid Replacement as one of their high priority conditions which means that any 
concerns identified with steroid replacement will trigger further case review. The focus therefore 
remains on this area and will continue to be so until we are fully assured that our processes for 
identifying and managing this condition are effective.  

•  The “overflow area” of the ED is no longer being used, having closed in October 2023. 

As a Trust, we have reflected on our practices as a result of Mr Pegg’s death. I hope the above 
demonstrates our commitment to ongoing learning and reassurance of our commitment to reinforce the 
NICE guidelines in relation to steroid treatment for patients. 

I trust that the foregoing has adequately addressed the Regulation 28 report issued subsequently to the 
inquest into the death of Mr Pegg.  

Should you require any further information in relation to this matter, please do not hesitate to ask. 

I confirm that I have not forwarded a copy of this response to any other Interested Person and would 
therefore be grateful if you could do so, as appropriate.  

Worcestershire Acute Hospitals NHS Trust | Executive Suite, Sky Level 3 | Worcestershire Royal Hospital 
Charles Hastings Way | Worcester | WR5 1DD 

 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 Office of the Managing Director  

I also confirm that the Trust is content for both the regulation 28 report and the response to be released 
or published should the Chief Coroner wish.   

Yours sincerely  

Managing Director   

Appendices 
1. WEDAdult 
2. Time Critical Medication Safety Flash v8 
3. Detect and Reflect -WEB 207182 Addisonian Crisis.  
4. Effective Handover June 

Worcestershire Acute Hospitals NHS Trust | Executive Suite, Sky Level 3 | Worcestershire Royal Hospital 
Charles Hastings Way | Worcester | WR5 1DD

Related reports

Other reports by David Reid

See all →

More reports categorised “Hospital Death (Clinical Procedures and medical management) related deaths”

See all →

Track Worcestershire Acute Hospitals NHS Trust

See every Prevention of Future Deaths report matching Worcestershire Acute Hospitals NHS Trust, and how often a new one appears.

What would an alert for this have sent me? Search the full text

Free to try — the preview shows the real matches and how many arrived in the last 12 months. Your first email alert is free.

These reports are published by the Chief Coroner's office at judiciary.uk and are © Crown copyright. The text here is reproduced from the published PDF so it can be searched. If something on this page is wrong, or you are a person named in it and want it reviewed, email drcjar@gmail.com and we will act promptly.